Johnson & Johnson vs The Goldman Sachs Group, Inc.
Johnson & Johnson is worth $650.673B, 2.1× the $302.952B market cap of The Goldman Sachs Group, Inc.. Updated daily.
| Metric | ||
|---|---|---|
| Market cap | $650.673B | $302.952B |
| Global rank | #1 | #2 |
| Share price | $270.00 | $1,040.46 |
| Change | +3.93% | +0.58% |
| Revenue | $94.193B | $58.283B |
| Net income | $26.804B | $17.176B |
| Country | United States | United States |
| Sector | Healthcare | Financial Services |
Want a wider comparison? Compare up to five companies.
Related comparisons
Frequently asked questions
- Is Johnson & Johnson bigger than The Goldman Sachs Group, Inc.?
- Johnson & Johnson has a market cap of $650.673B against $302.952B for The Goldman Sachs Group, Inc., making it 2.1 times as valuable.
- Which company earns more, JNJ or GS?
- Johnson & Johnson reported net income of $26.804B and The Goldman Sachs Group, Inc. reported $17.176B in their most recent annual periods.